Literature DB >> 14559795

Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.

Wei Jin1, Ivone G Bruno, Tong-Xin Xie, Laura J Sanger, Gilbert J Cote.   

Abstract

Exclusion of the alpha-exon by alternative RNA splicing of the fibroblast growth factor receptor 1 (FGFR1) primary transcript leads to the production of FGFR1beta. Glial cell transformation is associated with a progressive increase in FGFR1beta expression that coincides with a dramatic increase in the expression of the splicing factor polypyrimidine tract-binding protein (PTB). Cell-specific overexpression of PTB increased alpha-exon skipping, and a reduction in PTB increased alpha-exon inclusion. Targeted disruption of PTB interaction with FGFR1 precursor RNA in vivo by an antisense oligonucleotide also increased alpha-exon inclusion. These results suggest that PTB plays a direct role in alpha-exon splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559795

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

2.  The emerging role of splicing factors in cancer.

Authors:  Ana Rita Grosso; Sandra Martins; Maria Carmo-Fonseca
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

3.  Exon repression by polypyrimidine tract binding protein.

Authors:  Batoul Amir-Ahmady; Paul L Boutz; Vadim Markovtsov; Martin L Phillips; Douglas L Black
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

4.  Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription.

Authors:  Ian A Swinburne; Clifford A Meyer; X Shirley Liu; Pamela A Silver; Alexander S Brodsky
Journal:  Genome Res       Date:  2006-06-12       Impact factor: 9.043

5.  Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2.

Authors:  Niroshika Keppetipola; Shalini Sharma; Qin Li; Douglas L Black
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-02       Impact factor: 8.250

6.  Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.

Authors:  X He; M Pool; K M Darcy; S B Lim; N Auersperg; J S Coon; W T Beck
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

7.  The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.

Authors:  Guillermo Aldave; Marisol Gonzalez-Huarriz; Angel Rubio; Juan Pablo Romero; Datta Ravi; Belén Miñana; Mar Cuadrado-Tejedor; Ana García-Osta; Roeland Verhaak; Enric Xipell; Naiara Martinez-Vélez; Arlet Acanda de la Rocha; Montserrat Puigdelloses; Marc García-Moure; Miguel Marigil; Jaime Gállego Pérez-Larraya; Oskar Marín-Bejar; Maite Huarte; Maria Stella Carro; Roberto Ferrarese; Cristobal Belda-Iniesta; Angel Ayuso; Ricardo Prat-Acín; Fernando Pastor; Ricardo Díez-Valle; Sonia Tejada; Marta M Alonso
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

8.  Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.

Authors:  Chen Wang; John T Norton; Supurna Ghosh; Julie Kim; Kazuo Fushimi; Jane Y Wu; M Sharon Stack; Sui Huang
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

Review 9.  Misregulation of pre-mRNA alternative splicing in cancer.

Authors:  Jian Zhang; James L Manley
Journal:  Cancer Discov       Date:  2013-10-21       Impact factor: 39.397

10.  Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.

Authors:  Gilbert J Cote; Wen Zhu; Anthony Thomas; Emil Martin; Ferid Murad; Iraida G Sharina
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.